From Bench to Market: Regulatory and GMP Strategies for mRNA Therapeutics - 05.21.25
Houston Methodist DeBakey CV Education via YouTube
Gain a Splash of New Skills - Coursera+ Annual Just ₹7,999
AI Engineer - Learn how to integrate AI into software applications
Overview
Coursera Spring Sale
40% Off Coursera Plus Annual!
Grab it
Join this 57-minute cardiovascular live session titled "At the Cutting Edge of RNA Therapeutics" hosted by Kristopher Brannan, PhD, featuring presenter Felix Kern, PhD, Associate Director and Head of Compliance Launch and Technology Center at Merck KGaA. Explore the journey "From Bench to Market: Regulatory and GMP Strategies for mRNA Therapeutics" in this educational webinar from Houston Methodist DeBakey CV Education that delves into the cutting-edge developments in RNA therapeutic applications for cardiovascular medicine.
Syllabus
05.21.25 CV Live: At the Cutting Edge of RNA Therapeutics
Taught by
Houston Methodist DeBakey CV Education
Reviews
5.0 rating, based on 1 Class Central review
Showing Class Central Sort
-
This course provided an excellent bridge between academic research and real-world translation of mRNA therapeutics. It clearly explained regulatory pathways, GMP requirements, and quality considerations, helping me understand how discoveries move from the bench to clinical and commercial applications. The practical case studies and focus on manufacturing challenges made the content highly relevant for scientists aiming to work in translational or industrial settings.